PURPOSE Evaluate safety and efficacy of 0.75% phentolamine ophthalmic solution (POS),
an alpha-1 antagonist, in reversal of pharmacologically induced mydriasis. DESIGN Two …

Purpose To explore the efficacy of topical 2.6% EDTA ophthalmic solution (C-KAD) as a
treatment to improve visual function for the subgroup of patients with loss of contrast …

The invention provides methods, compositions, and kits containing phentolamine for
improving visual performance. In particular, the invention provides improvement in visual …

C07D233/04—Heterocyclic compounds containing 1, 3-diazole or hydrogenated 1, 3-
diazole rings, not condensed with other rings having one double bond between ring …

Questo studio si propone di analizzare e confrontare le aberrazioni oculari (prendendo in
considerazione l'indice globale RMS) con i disturbi della visione notturna, indagati …

Picture the following: It'sa routine Tuesday morning at work. Your first scheduled
appointment is a new patient. He's a 33-year-old carpenter, in for a routine eye examination …

NIGHT VISION DISTURBANCES (NVDs) constitute a challenging array of quality-of-vision
problems that eyecare providers encounter all too commonly. The current range of tools at …

This invention provides methods for synthesizing phentolamine mesylate from phentolamine
and methanesulfonic acid in the presence of acetone and water. The methods of the present …

US12016841B2 - Methods and compositions for treatment of presbyopia, mydriasis, and other
ocular disorders - Google Patents US12016841B2 - Methods and compositions for treatment of …

The perception of halos and other night vision disturbances is a common complaint in
clinical practice. Such visual disturbances must be assessed in order to fully characterize …